Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Daewoong Pharmaceutical Co., Ltd.

Established in 1945, Daewoong Pharmaceutical Co., Ltd. has the largest prescription drug sales in Korea and envisions itself to become a top 50 global healthcare company by 2010. Daewoong has maintained a steady growth rate in the double digits and has paid surplus dividends for the last 40 years.
In addition to its product portfolio, which includes 10 blockbuster products, Daewoong has built strong core competency for new drug development and has cultivated a cooperative culture for collaboration with global partners.

In the future, Daewoong will expand its global business with its foreign branches and global partners and become a global healthcare group which contributes to improving the quality of life for people worldwide.


Contact Details:
501-2 Samgye-Ri, Pogok-Myon
Yongin
Kyunggi-Do
South Korea
Tel:82 31 334 3200
Fax:82 31 322 7190
Email:skpark@daewoong.co.kr
WWW:

www.daewoong.co.kr/




BioNews Results for Daewoong Pharmaceutical Co., Ltd.:

KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments
Entrepreneur.com:  Nov 16 2009 4:20AM Matching: pharmaceutical
Pharmaceuticals : EmailWire.Com SEO Press Release Distribution Services and PharmaNewsWire.Com Present Free Ph
TMC Net:  Nov 14 2009 6:23PM Matching: pharmaceutical
KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments
Montana's News Station:  Nov 14 2009 5:59PM Matching: pharmaceutical
KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments
KSLA:  Nov 14 2009 4:28PM Matching: pharmaceutical
Teva Pharmaceutical Industries Limited - Financial And Strategic Analysis Review - New Report Published
OfficialSpin:  Nov 14 2009 10:17AM Matching: pharmaceutical
Promote your company here: BioNewsCast - Press Release Distribution

View more Daewoong Pharmaceutical Co., Ltd. news.

Daewoong Pharmaceutical Co., Ltd. Patents:

US Patent No.Title
7037491 Human thrombopoietin comprising glycosylation sited at residues 157 and 164
6541619 Fusion protein of hEGF and human angiogenin and process for preparing the same
6491904 Topical composition containing human epidermal growth factor
5652120 Gene coding human epidermal growth factor and process for preparing the same
5639878 Acyloxylation process for preparing 4-acyloxy-2-azetidinone derivatives

View more Daewoong Pharmaceutical Co., Ltd. patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 633 times since April 2007, the link to the organisation's website has been followed 112 times

Recent Search Terms used to find this page: Daewoong Pharmaceutical | Daewoong Pharmaceutical Co. Ltd. | daewoong pharma contsct details | daewoong pharmaceutical co | daewoong pharmaceutical co | daewoong pharmaceutical | daewoong pharmaceutical | Daewoong Pharmaceutical Co. | co ltd | daewoong.co.kr | .

Search for more companies in Yongin

Search for more companies in Kyunggi-Do



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Daewoong Pharmaceutical Co., Ltd.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.